SLC5A2 and atrial fibrillation: We further estimated the effect of the 20 circulating metabolites that were significantly associated with SGLT2 inhibition on AF and found that two metabolites were significantly associated with AF (Bonferroni-corrected P value threshold = 0.0025 [0.05/20]) (Supplementary Table 4, Fig. 2b).